NASDAQ:ATRC
AtriCure Stock News
$20.89
-1.33 (-5.99%)
At Close: May 03, 2024
AtriCure Announces Pricing of Public Offering of Common Stock
12:10am, Tuesday, 12'th May 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced the pricing of its underwritten offering of
AtriCure Announces Pricing of Public Offering of Common Stock
12:00am, Tuesday, 12'th May 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today anno
U.S. RESEARCH ROUNDUP-Acushnet Holdings, Equity Residential, Fiserv
06:02pm, Monday, 11'th May 2020
Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Acushnet Holdings, Equity Residential and Fiserv, on
Monday.
HIGHLIGHTS
AtriCure Announces Proposed Public Offering of Common Stock
11:16am, Monday, 11'th May 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced it has commenced a proposed underwritten pub
AtriCure Announces Proposed Public Offering of Common Stock
12:00am, Monday, 11'th May 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today anno
The Top Stocks To Buy Now
12:41am, Saturday, 09'th May 2020
Individual stock picking is increasingly important. Continue to concentrate on healthcare and technology. Here are the top stocks to buy now.
AtriCure Announces Results from CONVERGE IDE Clinical Trial
12:47pm, Friday, 08'th May 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced the results from the CONVERGE IDE clinical t
May 08, 2020 Xherald --
Global Atrial Appendage Occluder Market, delivering a must-read report for industry stakeholders wanting to understand the strategic...
AtriCure Announces Results from CONVERGE IDE Clinical Trial
12:00am, Friday, 08'th May 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today anno
Q1 2020 Earnings Forecast for AtriCure Inc. (NASDAQ:ATRC) Issued By SVB Leerink
06:22am, Saturday, 02'nd May 2020
AtriCure Inc. (NASDAQ:ATRC) – SVB Leerink increased their Q1 2020 earnings estimates for shares of AtriCure in a report released on Tuesday, April 28th. SVB Leerink analyst D. Antalffy now anticipat
Edited Transcript of VRAY earnings conference call or presentation 30-Apr-20 8:30pm GMT
07:34am, Friday, 01'st May 2020
Q1 2020 ViewRay Inc Earnings Call
AtriCure Inc (ATRC) Q1 2020 Earnings Call Transcript
03:00pm, Thursday, 30'th Apr 2020
ATRC earnings call for the period ending March 31, 2020.
AtriCure Announces Investor Update Webcast on May 8, 2020 in Conjunction with the 41st Annual Heart Rhythm Society (HRS) Virtual Meeting
12:30pm, Thursday, 30'th Apr 2020
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will host an analyst and in
